These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Treatment options and considerations for the newly diagnosed myeloma patient. Rajkumar VS; Oncology (Williston Park); 2005 Sep; 19(10):1260, 1262, 1267 passim. PubMed ID: 16285223 [No Abstract] [Full Text] [Related]
14. Multiple myeloma in the era of novel agents. Dimopoulos MA; Attal M Semin Hematol; 2009 Apr; 46(2):107-9. PubMed ID: 19389493 [No Abstract] [Full Text] [Related]
15. [Indications for chemotherapy in multiple myeloma]. Heyll A; Aul C Dtsch Med Wochenschr; 1996 May; 121(20):675. PubMed ID: 8635404 [No Abstract] [Full Text] [Related]
16. Lenalidomide and thalidomide: an evolving paradigm for the management of multiple myeloma. Anderson KC; Prince HM Semin Hematol; 2005 Oct; 42(4 Suppl 4):S1-2. PubMed ID: 16344096 [No Abstract] [Full Text] [Related]
17. [Are drug combinations useful in multiple myeloma?]. Pavlovsky S Sangre (Barc); 1984; 29(5):872-5. PubMed ID: 6523339 [No Abstract] [Full Text] [Related]
18. [Improved prognosis of generalized AL-amyloidosis in a patient with multiple myeloma treated according to the VAD protocol]. Sarkisova IA; Rameev VV; Kozlovskaia LV; Andreeva NE Ter Arkh; 2003; 75(8):81-2. PubMed ID: 14520860 [No Abstract] [Full Text] [Related]
19. Management of newly diagnosed myeloma. Rajkumar SV; Palumbo A Hematol Oncol Clin North Am; 2007 Dec; 21(6):1141-56, ix-x. PubMed ID: 17996592 [TBL] [Abstract][Full Text] [Related]
20. [Results, failures and perspectives in therapy of multiple myeloma]. Bessmel'tsev SS; Abdulkadyrov KM Vopr Onkol; 2002; 48(2):146-52. PubMed ID: 12227061 [No Abstract] [Full Text] [Related] [Next] [New Search]